iNOS-Producing Inflammatory Dendritic Cells Constitute the Major Infected Cell Type during the Chronic Leishmania major Infection Phase of C57BL/6 Resistant Mice-Reference-Cited by-同舟云学术

iNOS-Producing Inflammatory Dendritic Cells Constitute the Major Infected Cell Type during the Chronic Leishmania major Infection Phase of C57BL/6 Resistant Mice

Published:2009-06-26 Issue:6 Volume:5 Page:e1000494
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

De Trez Carl,Magez Stefan,Akira Shizuo,Ryffel Bernhard,Carlier Yves,Muraille Eric

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference46 articles.

1. The Regulation of Immunity to Leishmania-Major.;SL Reiner;Annual Review of Immunology,1995

2. The immunology of susceptibility and resistance to Leishmania major in mice.;D Sacks;Nature Reviews Immunology,2002

3. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.;C Bogdan;Cellular Microbiology,2008

4. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens.;C Nathan;Proceedings of the National Academy of Sciences of the United States of America,2000

5. Tissue Expression of Inducible Nitric-Oxide Synthase Is Closely Associated with Resistance to Leishmania-Major.;S Stenger;Journal of Experimental Medicine,1994

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunomicrotope of Leishmania control and persistence;Trends in Parasitology;2024-09

2. Effect of Leishmania infantum infection on B cell lymphopoiesis and memory in the bone marrow and spleen;The FASEB Journal;2024-08-23

3. Brucella infection and Toll-like receptors;Frontiers in Cellular and Infection Microbiology;2024-03-12

4. Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya;EMBO Molecular Medicine;2024-02-08

5. Immunosuppressants alter the immune response associated with Glucantime® treatment for Leishmania infantum infection in a mouse model;Frontiers in Immunology;2023-12-01